Medisplint
Medisplint
Explore our high-performance clinical reconstruction implants, instrumentation, and trauma stabilization devices.
An Industry Whitepaper on Mechanical Integrity, Clinical Demands, and Advanced Manufacturing.
In modern sports medicine, the surgical reconstruction of the anterior cruciate ligament (ACL) and posterior cruciate ligament (PCL) demands fixation techniques that deliver immediate mechanical stability, minimal graft slippage, and optimal biological integration. Cortical fixation buttons have emerged as the gold standard for suspensory femoral fixation. These small, engineered plates anchor high-strength suture loops against the outer femoral cortex, resisting cyclic physiological loads during early mobilization and rehabilitation.
The global sports medicine market is undergoing rapid expansion, driven by rising participation in athletic activities, a growing aging population wishing to remain active, and significant technological breakthroughs in arthroscopic techniques. Cortical fixation systems occupy a central role in this market. The demand has shifted from simple fixed-loop constructs to highly engineered adjustable loop designs, which allow surgeons to custom-tension the graft in real-time, closing any remaining gap within the bone tunnel.
From an industrial perspective, original equipment manufacturers (OEMs) and contract manufacturing organizations (CMOs) face rigorous quality benchmarks. Global regulatory frameworks, including the transition from the Medical Device Directive (MDD) to the Medical Device Regulation (MDR) in Europe, and the strict FDA 510(k) clearance path in the United States, demand absolute traceability, material biocompatibility, and validated mechanical performance metrics.
Cortical fixation buttons are utilized across diverse localized clinical applications:
Demonstrable Expertise and Infrastructure Supporting Global Medical Brands.
Founded in 2016, Medisplint Orthopedic Instruments Co., Ltd. has established itself as an elite manufacturer specializing in orthopedic implants, fixation systems, and surgical instrumentation. With over 10 years of overall industry experience and a strong 7-year export pedigree, Medisplint services critical markets across Europe, Southeast Asia, the Middle East, and South America, yielding an annual export revenue exceeding USD 12 million.
Our commitment to quality is backed by international certifications, including ISO 13485 compliance and CE verification. The quality assurance pipeline is managed by 42 specialized inspectors overseeing incoming material verification, In-Process Quality Control (IPQC), Final Quality Control (FQC), and rigorous third-party laboratory validations. Through close collaboration with our 1,200+ supply chain partners, we ensure uninterrupted production capacity and rapid dispatch timelines.
Driving next-generation development in cortical fixation and sports medicine hardware.
The selection of raw materials is vital for the clinical longevity of cortical buttons. Medisplint utilizes medical-grade Titanium Alloy (Ti6Al4V ELI) conforming to ASTM F136. This alloy offers exceptional biocompatibility, fatigue limit threshold, and a modulus of elasticity closer to cortical bone than cobalt-chromium or stainless steel. When combined with ultra-high-molecular-weight polyethylene (UHMWPE) non-absorbable braided loops, our fixation constructs show minimal elongation under physiological cyclic loading conditions.
For years, fixed-loop systems were the standard, requiring surgeons to determine precise graft channel lengths preoperatively. However, this structure left little margin for error. The industry is moving towards Adjustable Loop Buttons utilizing self-locking loop mechanisms. Medisplint's technical roadmap focuses on reducing "slippage" or "creep" under repetitive loading—a common issue with inferior adjustable mechanisms. Our designs utilize a unique finger-trap configuration within the suture path to lock the loop when tensioned, eliminating the need for manual knotting and reducing graft micromotion.
Looking ahead, Medisplint is exploring the integration of bioactive coatings (such as hydroxyapatite or plasma-spray titanium) on the underside of cortical buttons. This surface modification aims to facilitate direct bone-to-implant contact, transforming standard mechanical fixation into biological integration and minimizing the risk of button migration or tissue irritation.
A transparent view inside our 18,500㎡ facility, demonstrating compliance and precision manufacturing.
Streamlined procurement, customized designs, and regulatory guidance for worldwide orthopedic buyers.
Medisplint operates as a strategic growth partner to global sports medicine brands. By providing comprehensive end-to-end solutions, we reduce the time-to-market for new products and lower manufacturing overheads.
Our engineering division, consisting of 85 development specialists, assists with complete implant geometry design, finite element analysis (FEA), and rapid prototyping. We can modify loop styles, button dimensions, pullout suture configurations, and add custom laser markings to meet the visual branding requirements of orthopedic distributors and medical institutions.
We provide full technical documentation and sterilization validation files (such as Gamma sterilization validation certificates, biocompatibility test results, and mechanical test logs in compliance with ASTM F2502 standards) to streamline approval processes with international regulatory agencies.
Our 18,500m² manufacturing plant features multi-axis CNC machines and automated cleaning lines, supporting batch sizes ranging from small clinical testing orders to high-volume commercial supply agreements. This scalability guarantees consistent dimensional precision and timely distribution schedules.
Answers to essential clinical, engineering, and commercial concerns for orthopedic partners.
Review our supplementary orthopedic product lines, veterinary kits, and power systems.
